These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND MYD88, Q99836, MYD88D, 4615 AND Prognosis
9 results:

  • 1. Key Genes Involved in the Beneficial Mechanism of Hyperbaric Oxygen for Glioblastoma and Predictive Indicators of Hyperbaric Oxygen Prolonging Survival in Glioblastoma Patients.
    Ren ZQ; Wang RD; Wang C; Ren XH; Li DG; Liu YL; Yu QH
    Curr Med Sci; 2024 Oct; 44(5):1036-1046. PubMed ID: 39446287
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Machine learning-based identification of a cell death-related signature associated with prognosis and immune infiltration in glioma.
    Zhou Q; Wu F; Zhang W; Guo Y; Jiang X; Yan X; Ke Y
    J Cell Mol Med; 2024 Jun; 28(11):e18463. PubMed ID: 38847472
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. SESN1 functions as a new tumor suppressor gene via Toll-like receptor signaling pathway in neuroblastoma.
    Hua Z; Chen B; Gong B; Lin M; Ma Y; Li Z
    CNS Neurosci Ther; 2024 Mar; 30(3):e14664. PubMed ID: 38516781
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy.
    Mallardo D; Fordellone M; White A; Ottaviano M; Sparano F; Bailey M; Facchini AB; Ong S; Maiolino P; Caracò C; Church S; Cavalcanti E; Warren S; Budillon A; Cesano A; Simeone E; Chiodini P; Ascierto PA
    J Transl Med; 2023 Sep; 21(1):610. PubMed ID: 37684649
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A novel immunogenic cell death signature for the prediction of prognosis and therapies in glioma.
    Zhang J; Du J; Jin Z; Qian J; Xu J
    PeerJ; 2023; 11():e15615. PubMed ID: 37456890
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Upregulated Immunogenic cell-Death-Associated Gene Signature Predicts Reduced Responsiveness to Immune-Checkpoint-Blockade Therapy and Poor prognosis in High-Grade Gliomas.
    Tang X; Guo D; Yang X; Chen R; Jiang Q; Zeng Z; Li Y; Li Z
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429083
    [No Abstract]    [Full Text] [Related]  

  • 7. Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma.
    Cai J; Hu Y; Ye Z; Ye L; Gao L; Wang Y; Sun Q; Tong S; Yang J; Chen Q
    Front Immunol; 2022; 13():1011757. PubMed ID: 36325335
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Exosomal SNHG16 secreted by CSCs promotes glioma development via TLR7.
    Zhang R; Li P; Lv H; Li N; Ren S; Xu W
    Stem Cell Res Ther; 2021 Jun; 12(1):349. PubMed ID: 34134771
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Bioinformatic analysis of gene expression and methylation regulation in glioblastoma.
    Wang W; Zhao Z; Wu F; Wang H; Wang J; Lan Q; Zhao J
    J Neurooncol; 2018 Feb; 136(3):495-503. PubMed ID: 29168084
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.